Frequently Asked Questions
The market is segmented based on Segmentation, By Product & Service (Instrument, Consumables, Antibodies, Others), End User (Pathology Labs, Research Institutes, Hospitals, Others), Application (Disease Diagnosis, Drug Discovery & Development, Other Applications) – Industry Trends and Forecast to 2031.
.
The Global Anatomic Pathology Market size was valued at USD 21.30 USD Billion in 2023.
The Global Anatomic Pathology Market is projected to grow at a CAGR of 6.85% during the forecast period of 2024 to 2031.
The major players operating in the market include , F. Hoffmann,La Roche , Mylan N.V. , Teva Pharmaceutical Industries , Sanofi , Pfizer , GlaxoSmithKline plc , Novartis AG , Bayer AG , Eli Lilly and Company , Merck & Co. , Allergan , AstraZeneca , Johnson & Johnson Private Limited , Cipla , Bausch Health Companies , Abbott ,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
